INS and transient ischemic attack: Possible imbalances, for which we did not adjust in the absence of specific information, could never, however, explain the absence of excess risk in diabetic patients not on insulin vs non-diabetic patients for stroke/TIA/systemic embolism, MI and bleeding, and, therefore, cannot be considered a substantial limitation of the present report.